Don't want ads? Subscribe or login now.

Merck Gets PTAB To Nix Johns Hopkins Cancer Drug Patent

By Theresa Schliep · June 10, 2025, 3:18 PM EDT

Merck & Co. Inc. subsidiary Merck Sharp & Dohme LLC has notched a win at the Patent Trial and Appeal Board in its disagreement with Johns Hopkins University over a cancer research...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Final Written Decision

Case Information

Case Title

Merck Sharp & Dohme LLC v. The Johns Hopkins University

Case Number

1:22-cv-03059

Court

Maryland

Nature of Suit

Patent

Date Filed

November 29, 2022

Recent Articles By Theresa

October 28, 2025
Apple Spared From Some Masimo Patent Claims Before Trial
October 17, 2025
Mixed Discretionary Denial Batch Caps Off Big Week For PTAB
October 06, 2025
High Court Turns Down 6 Patent Cases At Start Of Term
October 02, 2025
Fed. Circ. Affirms Cutting $10M Med Device IP Verdict To $1
September 02, 2025
Confusion Over Slashed Patent Verdict Vexes Fed. Circ. Judge
August 28, 2025
CBP, ITC Say Masimo Suit Over Apple Watch Ruling Misplaced
August 20, 2025
Masimo Targets CBP Over Latest Apple Watch Import Ruling
July 17, 2025
Senators Float 'Patent Thicket' Bill To Limit Generic Litigation
June 30, 2025
Tillis, Senate IP Leader, Announces Retirement
June 06, 2025
Fed. Circ. Weighs Purview Over Acorda's $17M Arbitral Award